Market Cap | ₹26,077Cr |
ROE | 22.42% |
P/E Ratio(TTM) | 50.82 |
EPS(TTM) | 61.25 |
P/B Ratio | 12.00 |
Dividend Yield | 0.77% |
Industry P/E | 65.65 |
Book Value | 259.37 |
Debt to Equity | 0.07 |
Face Value | 10 |
Parent Organisation | Dr Lal PathLabs Limited |
Managing Director | Dr. Om Manchanda |
NSE Symbol | LALPATHLAB |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Metropolis Healthcare | NA (0.00%) | 69.74 | ||
Vijaya Diagnostic Centre | NA (0.00%) | 68.39 | ||
Thyrocare Technologies | NA (0.00%) | 57.78 | ||
Krsnaa Diagnostics | NA (0.00%) | 30.61 |